SCHEMBL6691471

SCHEMBL6691471

FC(F)(F)c1ccccc1CNc1ccc(NCc2ccccc2C(F)(F)F)c(Cl)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UTS2R Q9UKP6 1/20 0.56
MAPT P10636 5/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
L3MBTL1 Q9Y468 3/20 0.51
CYP3A4 P08684 2/20 0.51
CYP1A2 P05177 2/20 0.51
CYP2C9 P11712 2/20 0.51
CYP2C19 P33261 2/20 0.51
ATM Q13315 1/20 0.51
PLA2G1B P04054 1/20 0.51
CYP2D6 P10635 1/20 0.51
ATG4B Q9Y4P1 1/20 0.51
P2RX7 Q99572 1/20 0.46
GAA P10253 1/20 0.45
ALDH1A1 P00352 3/20 0.43
KCNJ5 P48544 1/20 0.43
KCNJ3 P48549 1/20 0.43
NR1H2 P55055 1/20 0.42
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6691733 0.82 MAPT (0.55) MAPTMEN1KMT2AL3MBTL1CYP3A4
SCHEMBL4355638 0.81 UTS2R (0.51) UTS2RMAPTMEN1KMT2AL3MBTL1
SCHEMBL6692058 0.81 UTS2R (0.51) UTS2RMAPTMEN1KMT2AATM
SCHEMBL6695679 0.80 UTS2R (0.51) UTS2RMAPTCYP3A4P2RX7GAA
SCHEMBL6647057 0.76 HDAC3 (0.49) UTS2RMAPTMEN1KMT2AATM
SCHEMBL4341263 0.75 KDM4E (0.47) MAPTMEN1KMT2ACYP3A4ALDH1A1
SCHEMBL4359436 0.75 GAA (0.44) UTS2RMEN1KMT2ACYP3A4P2RX7
SCHEMBL30301286 0.74 MAPT (0.58) UTS2RMAPTMEN1KMT2ACYP3A4
SCHEMBL6692836 0.74 FFAR1 (0.49) L3MBTL1P2RX7KDM4E
SCHEMBL4604964 0.73 SLC22A12 (0.54) UTS2RMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040009973-A1 Phenylenediamine derivatives N-substituted with benzyl- or heteroarylmethyl- groups 4SC AG (DE) 2004-01-15 US disclosed
WO-2003076388-A2 BIS-ANILINE DERIVATIVES USEFUL AS POTASSIUM CHANNELS MODULATORS 4SC AG (DE) 2003-09-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040009973-A1 Phenylenediamine derivatives N-substituted with benzyl- or heteroarylmethyl- groups PAH, PNMT, OPRM1 UTS2R 1908/4885MAPT 3951/4885MEN1 960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.